摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

partial ethyl ester of norbornenedicarboxylic acid | 53414-25-8

中文名称
——
中文别名
——
英文名称
partial ethyl ester of norbornenedicarboxylic acid
英文别名
D,L-5-norbornene-2,3-dicarboxylic acid monoethyl ester;3-Ethoxycarbonylbicyclo[2.2.1]hept-5-ene-2-carboxylic acid
partial ethyl ester of norbornenedicarboxylic acid化学式
CAS
53414-25-8
化学式
C11H14O4
mdl
——
分子量
210.23
InChiKey
KQOXZRIHIPLKJD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    339.9±42.0 °C(Predicted)
  • 密度:
    1.275±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    partial ethyl ester of norbornenedicarboxylic acid双环[2,21]庚烷-2,3-二甲酸单甲酯 为溶剂, 生成 D,L-norbornane-2,3-dicarboxylic acid monoethyl ester
    参考文献:
    名称:
    5-Fluorouracil derivatives, and their pharmaceutical compositions
    摘要:
    一种化合物的化学式为:##STR1##其中R是从诺伯尼尔、诺伯烯基、双环[2,2,2]-庚基和金刚烷基中选择的桥环脂环基,可选择地被来自较低烷基、羧基、较低烷氧羰基、烷基二氧基、N,N-双(较低)烷基氨基甲酰、氨基、较低烷氧羰胺基和卤素的至少一种取代基取代。该化合物可用于治疗人类和动物的癌症。
    公开号:
    US04349552A1
  • 作为产物:
    参考文献:
    名称:
    Artem'eva; Kudryavtsev; Kukarkina, Russian Journal of Applied Chemistry, 2000, vol. 73, # 1, p. 125 - 130
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS
    申请人:CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD.
    公开号:US20170253614A1
    公开(公告)日:2017-09-07
    A series of hepatitis C virus (HCV) inhibitors and compositions and applications thereof in the preparation of drugs for treating chronic HCV infection. Especially, a series of compounds that are used as NS5A inhibitors, and compositions and uses thereof in the preparations of drugs.
    一系列丙型肝炎病毒(HCV)抑制剂及其组合物,以及在制备用于治疗慢性HCV感染的药物时的应用。特别是一系列用作NS5A抑制剂的化合物,以及在药物制剂中的组合物和用途。
  • Norbornene-based ring-opening polymerization polymer, product of hydrogenation of norbornene-based ring-opening polymerization polymer, and processes for producing these
    申请人:Taguchi Kazunori
    公开号:US20050148746A1
    公开(公告)日:2005-07-07
    A norbornene ring-opened polymer which in the molecule has repeating units represented by the formula (1): wherein R 1 represents Q, R 2 represents Q or C(═O)R 5 , R 3 represents Q or C(═O)R 6 , and R 4 represents Q or X—C(═O)R 7 (wherein Q represents hydrogen, a C 1-10 hydrocarbon group, etc.; R 5 , R 6 and R 7 each represents hydroxyl, C 1-10 alkoxyl, etc., provided that R 6 and R 7 may be bonded to each other to constitute oxygen, NH, etc.; X represents methylene, etc., provided that when R 2 is Q, then R 3 is C(═O)R 6 and R 4 is X—C(═O)R 7 and that when R 4 is Q, then R 2 is C(═O)R 5 , R 3 is C(═O)R 6 , and the configuration of R 2 and R 3 is trans, and m is 0 or 1), the polymer having a weight-average molecular weight as determined by gel permeation chromatography of 1,000 to 1,000,000. Also provided is a hydrogenation product of the norbornene ring-opened polymer. The norbornene ring-opened polymer and the hydrogenation product are excellent in heat resistance, electrical properties, etc.
    分子中具有由公式(1)表示的重复单元的去氢萘环开环聚合物:其中R1表示Q,R2表示Q或C(═O)R5,R3表示Q或C(═O)R6,R4表示Q或X—C(═O)R7(其中Q表示氢,C1-10烃基等;R5,R6和R7分别表示羟基,C1-10烷氧基等,但是当R6和R7结合形成氧,NH等时除外;X表示亚甲基等,但是当R2为Q时,R3为C(═O)R6,R4为X—C(═O)R7,当R4为Q时,R2为C(═O)R5,R3为C(═O)R6,并且R2和R3的构型为反式,m为0或1),该聚合物的重均分子量由凝胶渗透色谱法确定为1,000至1,000,000。还提供了去氢萘环开环聚合物的氢化产物。去氢萘环开环聚合物和氢化产物在耐热性,电学性能等方面表现出色。
  • RESIN COMPOSITION AND SEMICONDUCTOR DEVICE BOARD
    申请人:Osaku Yumi
    公开号:US20140087136A1
    公开(公告)日:2014-03-27
    A resin composition which contains a binder resin (A), radiation-sensitive compound (B), silane-modified resin (C), and antioxidant (D), wherein a content of the silane-modified resin (C) is 0.1 to 150 parts by weight with respect to 100 parts by weight of the binder resin (A), a content of the antioxidant (D) is 0.1 to 10 parts by weight with respect to 100 parts by weight of the binder resin (A), and an amount of warping is 14 μm or less when using the resin composition to form a thickness 2 to 3 μm resin film and baking the formed resin film at 230° C. is provided.
    一种树脂组合物,包含粘合剂树脂(A),辐射敏感化合物(B),硅改性树脂(C)和抗氧化剂(D),其中硅改性树脂(C)的含量相对于100份粘合剂树脂(A)为0.1至150份重量,抗氧化剂(D)的含量相对于100份粘合剂树脂(A)为0.1至10份重量,并且使用该树脂组合物形成2至3μm厚度的树脂膜并在230°C下烘烤形成的树脂膜翘曲量为14μm或以下。
  • 5-Fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:EP0010941A1
    公开(公告)日:1980-05-14
    The present invention provides compounds of the general formula:- wherein R is an optionally substituted bridged alicyclic radical or a substituted lower alkyl radical, the substituent being an optionally substituted bridged alicyclic group, an amino, protected amino, lower alkoxy, acyl, lower alkylthio, cyano(lower)alkylthio, arylthio or optionally substituted heterocyclic radical or a carboxy and esterified carboxy group, with the proviso, that when the substituent is a carboxy or esterified carboxy group then the lower alkyl radical contains 3 to 6 carbon atoms; or an unsubstituted or substituted lower alkenyl radical, the substituent being an optionally substituted bridged alicyclic group, an optionally substituted aryl radical or an optionally substituted heterocyclic radical; or a halophenyl radical; or an optionally substituted heterocyclic radical. 'The present invention also provides processes for the preparation of these compounds and pharmaceutical composition containing them. Furthermore, the present invention is concerned with a method of treating cancer which comprises administering these compounds to mammals suffering from cancer.
    本发明提供通式为:- 的化合物。 其中 R 是任选取代的桥式脂环基或取代的低级烷基,取代基是任选取代的桥式脂环基、氨基、保护氨基、低级烷氧基、酰基、低级烷硫基、氰基(低级)烷硫基、芳硫基或任选取代的杂环基或羧基和酯化羧基,但条件是当取代基是羧基或酯化羧基时,低级烷基含有 3 至 6 个碳原子;或未取代或取代的低级烯基,取代基为任选取代的桥式脂环基、任选取代的芳基或任选取代的杂环基;或卤代苯基;或任选取代的杂环基。 '本发明还提供了制备这些化合物和含有这些化合物的药物组合物的工艺。此外,本发明还涉及一种治疗癌症的方法,该方法包括对患有癌症的哺乳动物施用这些化合物。
  • CATALYST FOR NORBORNENE MONOMER POLYMERIZATION AND METHOD FOR PRODUCING NORBORNENE POLYMER
    申请人:Showa Denko K.K.
    公开号:EP2634197A1
    公开(公告)日:2013-09-04
    The invention relates to a catalyst for the polymerization of norbornene monomers comprising transition metal complex (A) represented by formula (1); and a method for producing a norbornene (co)polymer, especially a norbornene copolymer containing a monomer unit represented by formulae (2) and (3), wherein a norbornen monomer is homopolyzed or copolymerized in the presence of the polymerization catalyst. Preferable examples of the transition metal complex (A) include (π-allyl)4-(2,6-diisopropylphenylimino)-2-penten-2-olato-κ2N,O}palladium and (π-allyl)4-(1-naphthylimino)-2-penten-2-olato-κ2N,O}palladium. In the formulae, the symbols are as defined in the description. A norbornene (co)polymer which has excellent transparency, excellent heat resistance, excellently low water absorption and excellent electrical insulation characteristics can be efficiently produced by the present invention.
    本发明涉及一种用于降冰片烯单体聚合的催化剂,该催化剂包括由式(1)表示的过渡金属络合物(A);以及一种生产降冰片烯(共)聚合物,特别是含有由式(2)和(3)表示的单体单元的降冰片烯共聚物的方法,其中降冰片烯单体在该聚合催化剂存在下均聚或共聚。过渡金属配合物(A)的优选实例包括(π-烯丙基)4-(2,6-二异丙基苯基亚氨基)-2-戊烯-2-醇基-κ2N,O}钯和(π-烯丙基)4-(1-萘基亚氨基)-2-戊烯-2-醇基-κ2N,O}钯。式中的符号与说明中的定义相同。本发明可以有效地生产出一种具有优异透明度、优异耐热性、优异低吸水性和优异电绝缘特性的降冰片烯(共)聚合物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物